TherapeuticsMD, Inc.TXMDNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +32.87% | +25.56% | +306.84% | +43.33% |
| Gross Profit Growth | +0.00% | +0.00% | +25.56% | +306.84% | +43.33% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +7.77% | +0.00% | +0.17% | +0.36% | +0.36% |
| Weighted Average Shares Diluted Growth | +7.77% | +0.00% | +0.17% | +0.36% | +0.36% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +6136.36% | -63.76% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +6136.36% | -63.76% | +0.00% |
| Receivables Growth | +22.85% | +15.28% | -7.01% | +28.71% | +10.29% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -21.67% | -10.36% | -9.15% | -4.04% | -2.23% |
| Book Value per Share Growth | -10.38% | -6.55% | -6.87% | -1.72% | +0.92% |
| Debt Growth | -9.80% | -10.37% | -10.65% | -13.03% | -12.39% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |